Maryland State Retirement & Pension System’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$924K Buy
2,923
+51
+2% +$12K 0.02% 606
2026
Q1
$573K Hold
2,872
– – 0.01% 748
2025
Q4
$543K Buy
2,872
+61
+2% +$11.7K 0.01% 782
2025
Q3
$498K Sell
2,811
-2,859
-50% -$425K 0.01% 813
2025
Q2
$645K Buy
5,670
+151
+3% +$16.1K 0.01% 810
2025
Q1
$580K Sell
5,519
-844
-13% -$95.4K 0.01% 830
2024
Q4
$682K Buy
6,363
+194
+3% +$21.9K 0.01% 864
2024
Q3
$617K Buy
6,169
+263
+4% +$26.5K 0.01% 938
2024
Q2
$498K Hold
5,906
– – 0.01% 1148
2024
Q1
$469K Sell
5,906
-103
-2% -$7.59K 0.01% 1158
2023
Q4
$429K Hold
6,009
– – 0.01% 1223
2023
Q3
$360K Sell
6,009
-454
-7% -$29.9K 0.01% 1252
2023
Q2
$466K Hold
6,463
– – 0.01% 1140
2023
Q1
$475K Sell
6,463
-168
-3% -$11.9K 0.01% 1070
2022
Q4
$443K Buy
+6,631
New +$431K 0.01% 1075
2022
Q3
– Sell
-10,957
Closed -$610K – 806
2022
Q2
$610K Buy
10,957
+214
+2% +$12.1K 0.02% 796
2022
Q1
$754K Buy
10,743
+64
+0.6% +$4.64K 0.02% 769
2021
Q4
$1.03M Buy
10,679
+160
+2% +$14.8K 0.03% 628
2021
Q3
$922K Buy
+10,519
New +$814K 0.03% 665

Other funds holding LGND

Maryland State Retirement & Pension System's LGND Position: Q2 2026 in Review

Maryland State Retirement & Pension System increased its Ligand Pharmaceuticals (LGND) stake by 1.8% in Q2 2026, buying an estimated $12K and bringing the position to 2,923 shares worth $924K. The position accounts for 0.02% of the portfolio, ranked #606.

Maryland State Retirement & Pension System first reported a position in LGND in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.03M in Q4 2021. 417 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Maryland State Retirement & Pension System held 2,923 shares of Ligand Pharmaceuticals worth $924K as of Q2 2026.
  • Maryland State Retirement & Pension System bought 51 Ligand Pharmaceuticals shares in Q2 2026, an estimated $12K.
  • Ligand Pharmaceuticals made up 0.02% of Maryland State Retirement & Pension System's portfolio in Q2 2026, its #606 holding.
  • Maryland State Retirement & Pension System first reported a position in Ligand Pharmaceuticals in Q3 2021 and has held it in 19 quarters since.
  • Maryland State Retirement & Pension System's Ligand Pharmaceuticals position peaked at $1.03M in Q4 2021.
  • 417 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Maryland State Retirement & Pension System's 13F filing for Q2 2026, filed 30 Jul 2026.